These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6555053)

  • 1. The treatment with L-aspartic acid of persons addicted to opiates.
    Koyuncuoğlu H
    Bull Narc; 1983; 35(1):11-5. PubMed ID: 6555053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the suppressive effects of L-aspartic acid and chlorpromazine + diazepam treatments on opiate abstinence syndrome signs in men.
    Sener AI; Ceylan ME; Koyuncuoğlu H
    Arzneimittelforschung; 1986 Nov; 36(11):1684-6. PubMed ID: 3814227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid (vitamin C) effects on withdrawal syndrome of heroin abusers.
    Evangelou A; Kalfakakou V; Georgakas P; Koutras V; Vezyraki P; Iliopoulou L; Vadalouka A
    In Vivo; 2000; 14(2):363-6. PubMed ID: 10836211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients.
    Koyuncuoglu H
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):13-9. PubMed ID: 7711985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal findings in children of drug-addicted mothers].
    Echevarría J; Callen M; Alustiza E; Orueta Y; Traba L; Paisán L
    An Esp Pediatr; 1983 Dec; 19(6):439-43. PubMed ID: 6666886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
    Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
    Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pseudo junkie: evolution of the heroin lifestyle in the non-addicted individual.
    Gay GR; Senay EC; Newmeyer JA
    Anesth Analg; 1974; 53(2):241-7. PubMed ID: 4856132
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.
    De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B9-15. PubMed ID: 11104938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Withdrawal in opiate addicts in an internal medicine hospital unit].
    Crémer GA; Boissonnas A
    Bull Acad Natl Med; 1995 Oct; 179(7):1335-51; discussion 1351-4. PubMed ID: 8556409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process evaluation of an out-patient detoxification service.
    Sannibale C; Fucito L; O'Connor D; Curry K
    Drug Alcohol Rev; 2005 Nov; 24(6):475-81. PubMed ID: 16361203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough mixtures: not always for cough.
    Sim MG; Hulse GK; Khong E
    Aust Fam Physician; 2004 May; 33(5):327-31. PubMed ID: 15227862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug buprenorphine can treat patients addicted to heroin or prescription pain medications.
    Clark HW
    W V Med J; 2003; 99(1):42. PubMed ID: 12762216
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
    Ali R; Thomas P; White J; McGregor C; Danz C; Gowing L; Stegink A; Athanasos P
    Drug Alcohol Rev; 2003 Dec; 22(4):425-31. PubMed ID: 14660132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone.
    Bartu A; Freeman NC; Gawthorne GS; Allsop SJ; Quigley AJ
    Drug Alcohol Rev; 2002 Dec; 21(4):335-40. PubMed ID: 12537702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
    Lintzeris N
    Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.